In a randomized clinical trial of antibiotic treatments for community-acquired pneumonia, researchers did not find that monotherapy with ²-lactam alone was worse than a combination therapy with a macrolide in patients hospitalized with moderately severe pneumonia.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Kw-Lh-LyFro/141006174316.htm
Randomized trial examines community-acquired pneumonia treatments
6 octubre 2014
Volver